GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » Sloan Ratio %

ODYY (Odyssey Group International) Sloan Ratio % : 0.00% (As of Jul. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Odyssey Group International's Sloan Ratio for the quarter that ended in Jul. 2024 was 0.00%.

Warning Sign:

When sloan ratio (-107)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Jul. 2024, Odyssey Group International has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Odyssey Group International Sloan Ratio % Historical Data

The historical data trend for Odyssey Group International's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Group International Sloan Ratio % Chart

Odyssey Group International Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -916.32 -972.37 -107.00

Odyssey Group International Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Odyssey Group International's Sloan Ratio %

For the Medical Devices subindustry, Odyssey Group International's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Group International's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's Sloan Ratio % falls into.



Odyssey Group International Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Odyssey Group International's Sloan Ratio for the fiscal year that ended in Jul. 2024 is calculated as

Sloan Ratio=(Net Income (A: Jul. 2024 )-Cash Flow from Operations (A: Jul. 2024 )
-Cash Flow from Investing (A: Jul. 2024 ))/Total Assets (A: Jul. 2024 )
=(-0.842--1.215
-1)/0.586
=-107.00%

Odyssey Group International's Sloan Ratio for the quarter that ended in Jul. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jul. 2024 )
=(-0.842--1.216
-1)/0.586
=-106.83%

Odyssey Group International's Net Income for the trailing twelve months (TTM) ended in Jul. 2024 was -0.538 (Oct. 2023 ) + 13.278 (Jan. 2024 ) + -0.842 (Apr. 2024 ) + -12.74 (Jul. 2024 ) = $-0.84 Mil.
Odyssey Group International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jul. 2024 was -0.06 (Oct. 2023 ) + -0.908 (Jan. 2024 ) + -0.184 (Apr. 2024 ) + -0.064 (Jul. 2024 ) = $-1.22 Mil.
Odyssey Group International's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jul. 2024 was 0 (Oct. 2023 ) + 1 (Jan. 2024 ) + 0 (Apr. 2024 ) + 0 (Jul. 2024 ) = $1.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odyssey Group International  (OTCPK:ODYY) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jul. 2024, Odyssey Group International has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Odyssey Group International Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Odyssey Group International Business Description

Traded in Other Exchanges
N/A
Address
2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. The company have two different technologies in the research and development stage; the CardioMap heart monitoring and screening device, and the Save a Life choking rescue device.
Executives
Erik C. Emerson other: Chief Commercial Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda other: Chief Operating Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson director 2372 MORSE AVE., IRVINE CA 92614
Christine Farrell officer: Controller/Secretary 2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey director 2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy director 2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d director 2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond director, officer: President/CEO 10 CANTERBURY ROAD, WINDHAM NH 03087